Linkit® AX
Innovative Linkit® AX solution: Efficient aliquoting without manual effort
The Linkit® AX Aliquoting Solution is ideal for aliquoting small quantities of process fluids - quickly, even, and consistently from batch to batch.
The Linkit® AX Aliquoting Solution is ideal for aliquoting small quantities of process fluids – fast, even, and reproducible batch-to-batch in applications such as small-batch media preparation in cell & gene therapy operations.
The plug-&-play concept, combined with a ready-to-use patented manifold design, minimizes operator effort and error and consistently distributes fluid between the 10 bags with an accuracy of ±5.1% - 6.5%*. The solution is designed to address the pain points of manual filling and aliquoting applications without the need to heavily invest in big and complex equipment.
* ±5.1% for 250, 500 and 1,000 mL versions, ±6.5 % for 150 mL version
Reach higher throughput
Fast filling performance with a unique flow-through fluid design of the main hub.
Work confidently with more automation
QApp guides the operator during a filling operation, ensuring batch-to-batch repeatability.
Simplify Aliquoting Operations
Fully assembled, compact, and small footprint solution - no need to handle bulky and complicated traditional manifolds.
Go paperless with compliant batch records
Full end-to-end traceability in compliance to FDA directive 21 CFR part 11 and EU Annex 11.
To support you in your regulatory needs, specific documentation is available upon request:
- Validation guide
- Extractables guide
- Technical drawing
- Inspection guide
- Product compliance statement
- Instructions for use
Request information about Linkit® AX now
Filling stations: Linkit® AX
Innovative Linkit® AX solution: Efficient aliquoting without manual effort
Product classification Linkit® AX
Product categories
Applications
Manufacturers of similar products
Find more filling stations and related products
Find Linkit® AX and related products in the theme worlds
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.